Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma

Neha Korde(United States Fish and Wildlife Service), Ola Landgren(University of Miami Health System), Constance M. Yuan(National Cancer Institute), Marcia Mulquin(National Cancer Institute), Elisabet E. Manasanch(National Institutes of Health), Cody J. Peer(National Institutes of Health), Li Weng, Liz Lamping(National Institutes of Health), Ashley Carpenter(National Cancer Institute), Seth M. Steinberg(National Institutes of Health), Mark Roschewski(National Cancer Institute), Katherine R. Calvo(National Institutes of Health Clinical Center), Manisha Bhutani(Carolinas Healthcare System), Tristan M. Sissung(National Institutes of Health), Mary Kwok(National Cancer Institute), Rene Costello(National Institutes of Health), George Carter(National Institutes of Health), Dickran Kazandjian(United States Food and Drug Administration), Yvonne Wall(National Institutes of Health), Karen Kurdziel(Center for Cancer Research), Sham Mailankody(Memorial Sloan Kettering Cancer Center), Maryalice Stetler‐Stevenson(National Cancer Institute), Raul C. Braylan(Center for Cancer Research), William D. Figg(National Cancer Institute), Liza Lindenberg(National Cancer Institute), Peter Wu(National Institutes of Health), Peter L. Choyke(National Cancer Institute), Nishant Tageja(National Institutes of Health), Schuyler C. Cunningham(National Institutes of Health), Verena Gounden(Center for Cancer Research), Adriana Zingone(National Cancer Institute), Yong Zhang(National Institutes of Health), Irina Marić(Center for Cancer Research), Diane C. Arthur(National Cancer Institute), Malek Faham, Candis Morrison(National Institutes of Health), Katherine A. Kong, Debra Burton(Burton Hospitals NHS Foundation Trust), Diamond Zuchlinski(National Cancer Institute)
JAMA Oncology
July 2, 2015
Cited by 309


Related Papers